Q1 2019 Holdings
Filed 2019-05-15 | 164 holdings | $184.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Conatus Pharmaceuticals Inc(CNATEUR)Call | COMM | 20600T108 | $162 | 150,000 | 0.0% |
| ImmunoGen Inc(IMGNEUR)Call | COMM | 45253H101 | $406 | 150,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COMM | 00773U108 | $835 | 159,237 | 0.0% |
| Osmotica Pharmaceuticals PLC | COMM | G6S41R101 | $911 | 253,089 | 0.0% |
| Apellis Pharmaceuticals, Inc(APLS) | COMM | 03753U106 | $967 | 49,580 | 0.0% |
| Portola Pharmaceuticals Inc | COMM | 737010108 | $1.0K | 30,000 | 0.0% |
| PDS Biotechnology Corporation(PDSB) | COMM | 70465T107 | $1.1K | 142,635 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COMM | 87164F105 | $1.1K | 213,359 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COMM | 189464100 | $1.7K | 66,635 | 0.0% |
| ArQule Inc(ARQLUSD) | COMM | 04269E107 | $1.7K | 355,725 | 0.0% |
| Galapagos NV(GLPG)Put | COMM | 36315X101 | $2.4K | 20,000 | 0.0% |
| Otonomy Inc | COMM | 68906L105 | $2.7K | 1,023,865 | 0.0% |
| FibroGen IncPut | COMM | 31572Q958 | $2.7K | 50,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COMM | 88322Q108 | $2.8K | 351,811 | 0.0% |
| Kala Pharmaceuticals Inc | COMM | 483119103 | $2.9K | 345,346 | 0.0% |
| XBiotech Inc(XBIT) | COMM | 98400H102 | $2.9K | 261,391 | 0.0% |
| Foamix Pharmaceuticals Ltd | COMM | M46135105 | $3.1K | 832,293 | 0.0% |
| FibroGen Inc(FGENEUR) | COMM | 31572Q808 | $3.2K | 59,017 | 0.0% |
| GW Pharmaceuticals PLC | ADR | 36197T103 | $3.4K | 20,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COMM | 31189P102 | $3.6K | 203,742 | 0.0% |
| Puma Biotechnology Inc(PBYI)Call | COMM | 74587V107 | $3.6K | 93,800 | 0.0% |
| Insmed Inc(INSM) | COMM | 457669307 | $4.1K | 140,057 | 0.0% |
| Synlogic Inc. | COMM | 87166L100 | $4.4K | 574,972 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COMM | 48283N106 | $4.4K | 1,671,770 | 0.0% |
| Incyte Corp(INCY) | COMM | 45337C102 | $4.6K | 53,097 | 0.0% |
| Orchard Therapeutics PLC | ADR | 68570P101 | $4.9K | 276,083 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COMM | 24344T101 | $5.0K | 214,604 | 0.0% |
| Intercept Pharmaceuticals Inc(ICPTUSD) | COMM | 45845P108 | $5.0K | 44,918 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | COMM | 75615P103 | $5.6K | 65,031 | 0.0% |
| Savara Inc(SVRA) | COMM | 805111101 | $5.7K | 766,672 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COMM | 427746102 | $5.7K | 233,651 | 0.0% |
| Blueprint Medicines Corp(2L9) | COMM | 09627Y109 | $5.8K | 71,866 | 0.0% |
| MorphoSys AG | COMM | D55040105 | $6.3K | 69,344 | 0.0% |
| Biohaven Pharmaceutical Holding Company Ltd(BHVN) | COMM | G11196105 | $6.4K | 124,952 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COMM | 40637H109 | $6.5K | 401,329 | 0.0% |
| Xencor Inc(XNCR) | COMM | 98401F105 | $6.5K | 209,907 | 0.0% |
| Dermira Inc(DERMEUR) | COMM | 24983L104 | $6.6K | 483,640 | 0.0% |
| AnaptysBio Inc(ANAB) | COMM | 032724106 | $7.2K | 97,948 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COMM | 03152W109 | $7.9K | 584,108 | 0.0% |
| Entasis Therapeutics Holdings Inc. | COMM | 293614103 | $8.0K | 1,180,178 | 0.0% |
| Chiasma(CHMA) | COMM | 16706W102 | $8.5K | 1,630,221 | 0.0% |
| MacroGenics Inc(MGNX) | COMM | 556099109 | $9.4K | 523,756 | 0.0% |
| Biogen Inc(BIIB)Call | COMM | 09062X103 | $9.5K | 40,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COMM | 64125C109 | $9.9K | 112,406 | 0.0% |
| AstraZeneca PLC(AZN) | ADR | 046353108 | $10.6K | 261,577 | 0.0% |
| AbbVie Inc(ABBV)Call | COMM | 00287Y109 | $12.1K | 150,000 | 0.0% |
| Novo Nordisk A/S(NVO) | ADR | 670100205 | $13.0K | 247,734 | 0.0% |
| Allergan plc | COMM | G0177J108 | $13.0K | 88,665 | 0.0% |
| Iterum Therapeutics | COMM | G6333L101 | $13.7K | 1,726,514 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd | COMM CL A | G5269C101 | $16.7K | 922,700 | 0.0% |